|
Sign In to gain access to subscriptions and/or personal tools.
|
Multiple Sclerosis, Vol. 12, No. 6,
677-678 (2006)
DOI: 10.1177/1352458506073176
© 2006 SAGE Publications
Stem cell therapy in patients with multiple sclerosis
Neil Scolding
University of Bristol Institute of Clinical Neurosciences, Department of Neurology, Frenchay Hospital, Bristol, BS16 1LE, UK
References
- Rosenzweig A. Cardiac cell therapy-mixed results from mixed cells . N Engl J Med 2006; 355: 1274-1277 .[Free Full Text]
- Martino G, Pluchino S. The therapeutic potential of neural stem cells . Nat Rev Neurosci 2006; 7: 395-406 .[ISI][Medline]
[Order article via Infotrieve]
- Rice CM, Scolding NJ. Adult stem cells-reprogramming neurological repair? Lancet 2004; 364: 193-199 .[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, Gerdoni Eet al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy . Blood 2005; 106: 1755-1761 .[Abstract/Free Full Text]
- Coles AJ, Cox A, Le Page E, Jones J, Trip SA, Deans Jet al. The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy . J Neurol 2006; 253: 98-108 .[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Pender MP. The pathogenesis of primary progressive multiple sclerosis: antibody-mediated attack and no repair? J Clin Neurosci 2004; 11: 689-692 .[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Lublin FD, Baier M, Cutter G. Effect of relapses on development of residual deficit in multiple sclerosis . Neurology 2003; 61: 1528-1532 .[Abstract/Free Full Text]

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
|